Source: International Congress 2017 – Late-breaking studies in pulmonary diseases
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. Testov (Fryazino, Moscow Region, Russian Federation). Late Breaking Abstract - Frequency and characteristics of TB relapses. 2895

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Late Breaking Abstract - Atypical clinical and radiological presentation of SARS-CoV-2 infection in the elderly. Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020 Late Breaking Abstract - Clinical and epidemiological characteristics of Co-infection: respiratory tuberculosis and COVID-19. Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection Year: 2021 Late Breaking Abstract - Initiation of patient enrollment in treatment with BPaL in Ukraine: first intermediate results Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 Late Breaking Abstract - Therapeutic drug monitoring in a patient with very advanced XDR-TB Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis Year: 2021 Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Late Breaking Abstract - Patterns of inhaled corticosteroid-formoterol prescriptions in Poland Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts Year: 2019 Late Breaking Abstract - Impact of the SARS-CoV-2 pandemic on incidence and phenotype of tuberculosis in a UK hotspot Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease Year: 2021 Late Breaking Abstract - Asthma control in preschool and subsequent disease remission Source: International Congress 2019 – Asthma and the world Year: 2019 Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Late Breaking Abstract - Variable costs of sepsis in a Greek ICU Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence Year: 2021 Late Breaking Abstract - Recurrent Neural Networks and environmental data for COPD exacerbation prediction Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Late Breaking Abstract - Improving adherence to prescribing remdesivir in COVID-19 Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Late Breaking Abstract - Early follow-up of hospitalised and non-hospitalised patients with Covid-19 in a Swedish setting Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term Year: 2021 Late Breaking Abstract - Implications of new PH definition for CTEPD Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Late Breaking Abstract - Risk factors for chronic cough in 14669 individuals from the general population Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS Year: 2017 Late Breaking Abstract - Long COVID-19 symptoms including fatigue are more frequent in females independently of COVID-19 treatment Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021 Late Breaking Abstract - ‘Shielding’: Patient experience of measures to reduce risk of COVID-19 in those with pre-existing respiratory conditions Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020